Dermata Therapeutics, Inc.
DRMA • NASDAQ
Dermata Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Gerald T. Proehl, with a market cap of $3.3M.
CEOGerald T. Proehl
Next Earnings
Upcoming earnings announcement for Dermata Therapeutics, Inc.
Date
Wednesday, May 13, 2026 (in a month)
Timing
Before Market Open (9:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.72
Earnings History
Past 12 earnings reports for Dermata Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 26, 2026 | Q4 2025 | -$1.52Est: -$1.54 | +1.3% | - | — |  10-K |
| Nov 14, 2025 | Q3 2025 | -$1.65Est: -$1.59 | -3.8% | - | — | 10-Q |
| Aug 13, 2025 | Q2 2025 | -$1.66 | — | - | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.45 | — | - | — | 10-Q |
| Mar 17, 2025 | Q4 2024 | -$0.92 | — | - | — | 10-K |
| Nov 13, 2024 | Q3 2024 | -$2.04Est: -$2.64 | +22.7% | - | — | 10-Q |
| Aug 7, 2024 | Q2 2024 | -$4.18Est: -$3.79 | -10.3% | - | — | 10-Q |
| May 15, 2024 | Q1 2024 | -$7.05Est: -$5.40 | -30.6% | - | — | 10-Q |
| Mar 21, 2024 | Q4 2023 | -$3.15 | — | - | — | 10-K |
| Nov 9, 2023 | Q3 2023 | -$8.10Est: -$9.45 | +14.3% | - | — | — |
| Aug 10, 2023 | Q2 2023 | -$9.45Est: -$13.80 | +31.5% | - | — | 10-Q |
| May 11, 2023 | Q1 2023 | -$34.05Est: -$39.75 | +14.3% | - | — | — |